Specifically, by targeting human epidermal growth factor receptor 3 (HER3), miR-205 inhibits cell proliferation and migration and, by repressing ZEB1 and ZEB2, it limits tumor invasion8,22,23. This evidence concerns the gene ERBB3 and neoplasm.